LOVFF OTC
Cannara Biotech Inc.
1W: -2.0%
1M: +2.1%
3M: +25.4%
YTD: +13.8%
1Y: +15.6%
3Y: +113.1%
5Y: +2.8%
$1.48
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$107M
+31.3% ▲
5Y CAGR: +111.2%
Gross Profit
$47M
+58.5% ▲
5Y CAGR: +107.6%
Operating Income
$22M
+120.2% ▲
Net Income
$13M
+103.1% ▲
EPS (Diluted)
$0.14
+99.1% ▲
EBITDA
$28M
+85.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $17M | $36M | $57M | $82M | $107M |
| YoY Growth | +567.2% | +110.6% | +59.8% | +42.8% | +31.3% |
| Cost of Revenue | $7M | $19M | $30M | $52M | $60M |
| Gross Profit | $10M | $17M | $27M | $30M | $47M |
| Gross Margin | 60.5% | 48.4% | 47.6% | 36.4% | 44.0% |
| R&D Expenses | $2M | $1M | $1M | $1M | $711K |
| SG&A Expenses | $7M | $10M | $14M | $20M | $23M |
| Operating Expenses | $10M | $12M | $15M | $20M | $25M |
| Operating Income | $257K | $5M | $12M | $10M | $22M |
| Operating Margin | 1.5% | 13.8% | 20.8% | 12.3% | 20.7% |
| Interest Expense | $2M | $2M | $4M | $4M | $4M |
| Income Before Tax | -$2M | $2M | $7M | $4M | $18M |
| Tax Expense | $0 | $0 | $0 | -$2M | $5M |
| Net Income | -$2M | $2M | $7M | $6M | $13M |
| Net Margin | -9.0% | 6.4% | 12.1% | 7.9% | 12.2% |
| EPS (Diluted) | $-0.02 | $0.03 | $0.08 | $0.07 | $0.14 |
| EBITDA | $3M | $8M | $16M | $15M | $28M |
| Shares Outstanding | 77M | 88M | 89M | 92M | 92M |